{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:51:20Z","timestamp":1771012280087,"version":"3.50.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"S\u00e3o Paulo State Foundation for Research Support","award":["2021\/01475-9"],"award-info":[{"award-number":["2021\/01475-9"]}]},{"name":"S\u00e3o Paulo State Foundation for Research Support (FAPESP)","award":["2018\/18071-5"],"award-info":[{"award-number":["2018\/18071-5"]}]},{"name":"Brazilian National Council for the Scientific and Technological Development","award":["309316\/2021-9"],"award-info":[{"award-number":["309316\/2021-9"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04092-9","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T06:08:12Z","timestamp":1731305292000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phosphate metabolism: its impact on disorders of mineral metabolism"],"prefix":"10.1007","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-2761","authenticated-orcid":false,"given":"Maisa Monseff Rodrigues","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2617","authenticated-orcid":false,"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-3486","authenticated-orcid":false,"given":"Francisco J. A.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"issue":"1","key":"4092_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-020-00727-x","volume":"108","author":"S Minisola","year":"2021","unstructured":"S. Minisola, M.L. Brandi, Phosphate metabolism. Calcif. Tissue Int. 108(1), 1\u20132 (2021). https:\/\/doi.org\/10.1007\/s00223-020-00727-x","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"4092_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1681\/ASN.2010020186","volume":"22","author":"R Kumar","year":"2011","unstructured":"R. Kumar, J.R. Thompson, The regulation of parathyroid hormone secretion and synthesis. J. Am. Soc. Nephrol. 22(2), 216\u2013224 (2011). https:\/\/doi.org\/10.1681\/ASN.2010020186","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"4092_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/hdi.12010","volume":"17","author":"OS Iheagwara","year":"2013","unstructured":"O.S. Iheagwara, T.S. Ing, C.M. Kjellstrand, S.Q. Lew, Phosphorus, phosphorous, and phosphate. Hemodial. Int 17(4), 479\u2013482 (2013). https:\/\/doi.org\/10.1111\/hdi.12010","journal-title":"Hemodial. Int"},{"issue":"3","key":"4092_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00424-022-02668-w","volume":"474","author":"S Rausch","year":"2022","unstructured":"S. Rausch, M. F\u00f6ller, The regulation of FGF23 under physiological and pathophysiological conditions. Pflug. Arch. - Eur. J. Physiol. 474(3), 281\u2013292 (2022). https:\/\/doi.org\/10.1007\/s00424-022-02668-w","journal-title":"Pflug. Arch. - Eur. J. Physiol."},{"issue":"1","key":"4092_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep10974","volume":"5","author":"DB Kumssa","year":"2015","unstructured":"D.B. Kumssa, E.J.M. Joy, E.L. Ander et al. Dietary calcium and zinc deficiency risks are decreasing but remain prevalent. Sci. Rep. 5(1), 10974 (2015). https:\/\/doi.org\/10.1038\/srep10974","journal-title":"Sci. Rep."},{"issue":"05","key":"4092_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0030-1248255","volume":"42","author":"FJAD Paula","year":"2010","unstructured":"F.J.A.D. Paula, C.J. Rosen, Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling. Horm. Metab. Res 42(05), 299\u2013306 (2010). https:\/\/doi.org\/10.1055\/s-0030-1248255","journal-title":"Horm. Metab. Res"},{"key":"4092_CR7","doi-asserted-by":"publisher","first-page":"992666","DOI":"10.3389\/fendo.2022.992666","volume":"13","author":"I Portales-Castillo","year":"2022","unstructured":"I. Portales-Castillo, P. Simic, PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond. Front Endocrinol. 13, 992666 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.992666","journal-title":"Front Endocrinol."},{"issue":"7","key":"4092_CR8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/jbmr.3992","volume":"35","author":"AL Lecoq","year":"2020","unstructured":"A.L. Lecoq, P. Chaumet-Riffaud, A. Blanchard et al. Hyperparathyroidism in patients With X-linked hypophosphatemia. J. Bone Miner. Res. 35(7), 1263\u20131273 (2020). https:\/\/doi.org\/10.1002\/jbmr.3992","journal-title":"J. Bone Miner. Res."},{"key":"4092_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","volume":"127","author":"S DeLacey","year":"2019","unstructured":"S. DeLacey, Z. Liu, A. Broyles et al. Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients. Bone 127, 386\u2013392 (2019). https:\/\/doi.org\/10.1016\/j.bone.2019.06.025","journal-title":"Bone"},{"key":"4092_CR10","doi-asserted-by":"publisher","first-page":"688309","DOI":"10.3389\/fendo.2021.688309","volume":"12","author":"GI Baroncelli","year":"2021","unstructured":"G.I. Baroncelli, S. Mora, X-linked hypophosphatemic rickets: multisystemic disorder in children requiring multidisciplinary management. Front Endocrinol. 12, 688309 (2021). https:\/\/doi.org\/10.3389\/fendo.2021.688309","journal-title":"Front Endocrinol."},{"issue":"1","key":"4092_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.surg.2020.06.012","volume":"169","author":"C McManus","year":"2021","unstructured":"C. McManus, A. Oh, J.A. Lee, C. Hur, J.H. Kuo, Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis. Surgery 169(1), 94\u2013101 (2021). https:\/\/doi.org\/10.1016\/j.surg.2020.06.012","journal-title":"Surgery"},{"key":"4092_CR12","doi-asserted-by":"publisher","unstructured":"Kleinman R.E., Greer F.R., eds. Calcium, Phosphorus, and Magnesium. In: Pediatric Nutrition. 8th ed. American Academy of PediatricsItasca, IL; 2020. https:\/\/doi.org\/10.1542\/9781610023610-18","DOI":"10.1542\/9781610023610-18"},{"issue":"3","key":"4092_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4103\/0971-5916.198664","volume":"144","author":"R Goswami","year":"2016","unstructured":"R. Goswami, Primer on the metabolic bone diseases and disorders of mineral metabolism. Indian J. Med Res 144(3), 489 (2016). https:\/\/doi.org\/10.4103\/0971-5916.198664","journal-title":"Indian J. Med Res"},{"issue":"11","key":"4092_CR14","first-page":"151","volume":"1","author":"R Bouillon","year":"2004","unstructured":"R. Bouillon et al. Meeting report from the 26th annual meeting of the american society for bone and mineral research. Bonekey Rep. 1(11), 151\u2013154 (2004)","journal-title":"Bonekey Rep."},{"issue":"1","key":"4092_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1042\/BST20150223","volume":"44","author":"PR Angelova","year":"2016","unstructured":"P.R. Angelova, A.Y. Baev, A.V. Berezhnov, A.Y. Abramov, Role of inorganic polyphosphate in mammalian cells: from signal transduction and mitochondrial metabolism to cell death. Biochem. Soc. Trans. 44(1), 40\u201345 (2016). https:\/\/doi.org\/10.1042\/BST20150223","journal-title":"Biochem. Soc. Trans."},{"issue":"2","key":"4092_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1079\/PNS19760029","volume":"35","author":"DH Marshall","year":"1976","unstructured":"D.H. Marshall, B.E.C. Nordin, R. Speed, Calcium, phosphorus and magnesium requirement. Proc. Nutr. Soc. 35(2), 163\u2013173 (1976). https:\/\/doi.org\/10.1079\/PNS19760029","journal-title":"Proc. Nutr. Soc."},{"issue":"4","key":"4092_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1172\/JCI113172","volume":"80","author":"AA Portale","year":"1987","unstructured":"A.A. Portale, B.P. Halloran, R.C. Morris, Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J. Clin. Invest 80(4), 1147\u20131154 (1987). https:\/\/doi.org\/10.1172\/JCI113172","journal-title":"J. Clin. Invest"},{"issue":"2","key":"4092_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ndt\/gft417","volume":"29","author":"KJ Martin","year":"2014","unstructured":"K.J. Martin, G. Bell, K. Pickthorn et al. Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects. Nephrol. Dial. Transplant. 29(2), 385\u2013392 (2014). https:\/\/doi.org\/10.1093\/ndt\/gft417","journal-title":"Nephrol. Dial. Transplant."},{"key":"4092_CR19","doi-asserted-by":"publisher","unstructured":"Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. National Academies Press; 1997:5776. https:\/\/doi.org\/10.17226\/5776","DOI":"10.17226\/5776"},{"issue":"6","key":"4092_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0002-8223(98)00160-6","volume":"98","author":"AA Yates","year":"1998","unstructured":"A.A. Yates, S.A. Schlicker, C.W. Suitor, Dietary reference intakes. J. Am. Dietetic Assoc. 98(6), 699\u2013706 (1998). https:\/\/doi.org\/10.1016\/S0002-8223(98)00160-6","journal-title":"J. Am. Dietetic Assoc."},{"issue":"10","key":"4092_CR21","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3945\/jn.111.142257","volume":"141","author":"VL Fulgoni","year":"2011","unstructured":"V.L. Fulgoni, D.R. Keast, R.L. Bailey, J. Dwyer, Foods, fortificants, and supplements: where do americans get their nutrients? J. Nutr. 141(10), 1847\u20131854 (2011). https:\/\/doi.org\/10.3945\/jn.111.142257","journal-title":"J. Nutr."},{"issue":"2","key":"4092_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/j.ackd.2010.11.004","volume":"18","author":"Y Sabbagh","year":"2011","unstructured":"Y. Sabbagh, H. Giral, Y. Caldas, M. Levi, S.C. Schiavi, Intestinal phosphate transport. Adv. Chronic Kidney Dis. 18(2), 85\u201390 (2011). https:\/\/doi.org\/10.1053\/j.ackd.2010.11.004","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"4","key":"4092_CR23","doi-asserted-by":"publisher","first-page":"G355","DOI":"10.1152\/ajpgi.00244.2016","volume":"312","author":"E Candeal","year":"2017","unstructured":"E. Candeal, Y.A. Caldas, N. Guill\u00e9n, M. Levi, V. Sorribas, Intestinal phosphate absorption is mediated by multiple transport systems in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 312(4), G355\u2013G366 (2017). https:\/\/doi.org\/10.1152\/ajpgi.00244.2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"4092_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02279101","volume":"4","author":"LF B\u00e9langer","year":"1969","unstructured":"L.F. B\u00e9langer, Osteocytic osteolysis. Calc. Tis Res 4(1), 1\u201312 (1969). https:\/\/doi.org\/10.1007\/BF02279101","journal-title":"Calc. Tis Res"},{"key":"4092_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/bonekey.2012.229","volume":"1","author":"JJ Wysolmerski","year":"2012","unstructured":"J.J. Wysolmerski, Osteocytic osteolysis: time for a second look? Bonekey Rep. 1, 229 (2012). https:\/\/doi.org\/10.1038\/bonekey.2012.229","journal-title":"Bonekey Rep."},{"issue":"11","key":"4092_CR26","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1681\/ASN.2018121250","volume":"30","author":"L Thomas","year":"2019","unstructured":"L. Thomas, J. Xue, S.K. Murali, R.A. Fenton, J.A. Dominguez Rieg, T. Rieg, Pharmacological Npt2a inhibition causes phosphaturia and reduces plasma phosphate in mice with normal and reduced kidney function. JASN 30(11), 2128\u20132139 (2019). https:\/\/doi.org\/10.1681\/ASN.2018121250","journal-title":"JASN"},{"issue":"4","key":"4092_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ki.1996.135","volume":"49","author":"MP Kavanaugh","year":"1996","unstructured":"M.P. Kavanaugh, D. Kabat, Identification and characterization of a widely expressed phosphate transporter\/retrovirus receptor family. Kidney Int. 49(4), 959\u2013963 (1996). https:\/\/doi.org\/10.1038\/ki.1996.135","journal-title":"Kidney Int."},{"issue":"3","key":"4092_CR28","doi-asserted-by":"publisher","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","volume":"293","author":"LV Virkki","year":"2007","unstructured":"L.V. Virkki, J. Biber, H. Murer, I.C. Forster, Phosphate transporters: a tale of two solute carrier families. Am. J. Physiol. Ren. Physiol. 293(3), F643\u2013F654 (2007). https:\/\/doi.org\/10.1152\/ajprenal.00228.2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"4092_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-physiol-030212-183748","volume":"75","author":"J Biber","year":"2013","unstructured":"J. Biber, N. Hernando, I. Forster, Phosphate transporters and their function. Annu Rev. Physiol. 75(1), 535\u2013550 (2013). https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183748","journal-title":"Annu Rev. Physiol."},{"issue":"1","key":"4092_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00424-018-2207-z","volume":"471","author":"IC Forster","year":"2019","unstructured":"I.C. Forster, The molecular mechanism of SLC34 proteins: insights from two decades of transport assays and structure-function studies. Pflug. Arch. Eur. J. Physiol. 471(1), 15\u201342 (2019). https:\/\/doi.org\/10.1007\/s00424-018-2207-z","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"issue":"2-3","key":"4092_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mam.2012.07.007","volume":"34","author":"IC Forster","year":"2013","unstructured":"I.C. Forster, N. Hernando, J. Biber, H. Murer, Phosphate transporters of the SLC20 and SLC34 families. Mol. Asp. Med. 34(2-3), 386\u2013395 (2013). https:\/\/doi.org\/10.1016\/j.mam.2012.07.007","journal-title":"Mol. Asp. Med."},{"issue":"11","key":"4092_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrneph.2015.153","volume":"11","author":"LC Baia","year":"2015","unstructured":"for the NIGRAM investigators, L.C. Baia, I.P. Heilberg, G. Navis, M.H. De Borst, Phosphate and FGF-23 homeostasis after kidney transplantation. Nat. Rev. Nephrol. 11(11), 656\u2013666 (2015). https:\/\/doi.org\/10.1038\/nrneph.2015.153","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"4092_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ki.2011.60","volume":"80","author":"F Trepiccione","year":"2011","unstructured":"F. Trepiccione, G. Capasso, SGK3: a novel regulator of renal phosphate transport? Kidney Int. 80(1), 13\u201315 (2011). https:\/\/doi.org\/10.1038\/ki.2011.60","journal-title":"Kidney Int."},{"issue":"7","key":"4092_CR34","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2215\/CJN.09750913","volume":"10","author":"J Blaine","year":"2015","unstructured":"J. Blaine, M. Chonchol, M. Levi, Renal control of calcium, phosphate, and magnesium homeostasis. Clin. J. Am. Soc. Nephrol. 10(7), 1257\u20131272 (2015). https:\/\/doi.org\/10.2215\/CJN.09750913","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"4092_CR35","doi-asserted-by":"publisher","first-page":"F691","DOI":"10.1152\/ajprenal.90623.2008","volume":"296","author":"R Villa-Bellosta","year":"2009","unstructured":"R. Villa-Bellosta, S. Ravera, V. Sorribas et al. The Na + -P i cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary P i. Am. J. Physiol. Ren. Physiol. 296(4), F691\u2013F699 (2009). https:\/\/doi.org\/10.1152\/ajprenal.90623.2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"4092_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2016070726","volume":"28","author":"C Ansermet","year":"2017","unstructured":"C. Ansermet, M.B. Moor, G. Centeno et al. Renal fanconi syndrome and hypophosphatemic rickets in the absence of xenotropic and polytropic retroviral receptor in the nephron. JASN 28(4), 1073\u20131078 (2017). https:\/\/doi.org\/10.1681\/ASN.2016070726","journal-title":"JASN"},{"issue":"3","key":"4092_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/adc.57.3.217","volume":"57","author":"K Kruse","year":"1982","unstructured":"K. Kruse, U. Kracht, G. Gopfert, Renal threshold phosphate concentration (TmPO4\/GFR). Arch. Dis. Child. 57(3), 217\u2013223 (1982). https:\/\/doi.org\/10.1136\/adc.57.3.217","journal-title":"Arch. Dis. Child."},{"issue":"1","key":"4092_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0009-8981(69)90280-0","volume":"26","author":"OLM Bijvoet","year":"1969","unstructured":"O.L.M. Bijvoet, D.B. Morgan, P. Fourman, The assessment of phosphate reabsorption. Clin. Chim. Acta 26(1), 15\u201324 (1969). https:\/\/doi.org\/10.1016\/0009-8981(69)90280-0","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"4092_CR39","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1590\/S0100-879X2001000900006","volume":"34","author":"FJA Paula","year":"2001","unstructured":"F.J.A. Paula, C.M.M. Lanna, T. Shuhama, M.C. Foss, Effect of metabolic control on parathyroid hormone secretion in diabetic patients. Braz. J. Med Biol. Res 34(9), 1139\u20131145 (2001). https:\/\/doi.org\/10.1590\/S0100-879X2001000900006","journal-title":"Braz. J. Med Biol. Res"},{"issue":"2","key":"4092_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1590\/S0100-879X2002000200012","volume":"35","author":"CMM Lanna","year":"2002","unstructured":"C.M.M. Lanna, F.J.A. Paula, R.M. Montenegro Jr., A.C. Moreira, M.C. Foss, Parathyroid hormone secretion in chronic human endogenous hypercortisolism. Braz. J. Med Biol. Res 35(2), 229\u2013236 (2002). https:\/\/doi.org\/10.1590\/S0100-879X2002000200012","journal-title":"Braz. J. Med Biol. Res"},{"issue":"9","key":"4092_CR41","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1681\/ASN.V1191712","volume":"11","author":"Y Almad\u00e9n","year":"2000","unstructured":"Y. Almad\u00e9n, A. Canalejo, E. Ballesteros, AN[Combining Tilde]\u00d3N G, M. Rodr\u00edguez, Effect of high extracellular phosphate concentration on arachidonic acid production by parathyroid tissue in vitro. J. Am. Soc. Nephrol. 11(9), 1712\u20131718 (2000). https:\/\/doi.org\/10.1681\/ASN.V1191712","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"4092_CR42","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1523-1755.2001.059003855.x","volume":"59","author":"AS Dusso","year":"2001","unstructured":"A.S. Dusso, T. Pavlopoulos, L. Naumovich et al. p21WAF1 and transforming growth factor-\u03b1 mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int. 59(3), 855\u2013865 (2001). https:\/\/doi.org\/10.1046\/j.1523-1755.2001.059003855.x","journal-title":"Kidney Int."},{"issue":"4","key":"4092_CR43","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1210\/endo.139.4.5925","volume":"139","author":"S Tatsumi","year":"1998","unstructured":"S. Tatsumi, H. Segawa, K. Morita et al. Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands 1. Endocrinology 139(4), 1692\u20131699 (1998). https:\/\/doi.org\/10.1210\/endo.139.4.5925","journal-title":"Endocrinology"},{"key":"4092_CR44","doi-asserted-by":"publisher","first-page":"e13662","DOI":"10.7554\/eLife.13662","volume":"5","author":"Y Geng","year":"2016","unstructured":"Y. Geng, L. Mosyak, I. Kurinov et al. Structural mechanism of ligand activation in human calcium-sensing receptor. eLife 5, e13662 (2016). https:\/\/doi.org\/10.7554\/eLife.13662","journal-title":"eLife"},{"issue":"7","key":"4092_CR45","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1210\/me.2005-0333","volume":"20","author":"M Dinur","year":"2006","unstructured":"M. Dinur, R. Kilav, A. Sela-Brown, H. Jacquemin-Sablon, T. Naveh-Many, In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability. Mol. Endocrinol. 20(7), 1652\u20131660 (2006). https:\/\/doi.org\/10.1210\/me.2005-0333","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"4092_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00223-019-00636-8","volume":"108","author":"K Kritmetapak","year":"2021","unstructured":"K. Kritmetapak, R. Kumar, Phosphate as a signaling molecule. Calcif. Tissue Int 108(1), 16\u201331 (2021). https:\/\/doi.org\/10.1007\/s00223-019-00636-8","journal-title":"Calcif. Tissue Int"},{"issue":"10","key":"4092_CR47","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1096\/fj.08-107250","volume":"22","author":"M Nechama","year":"2008","unstructured":"M. Nechama, I.Z. Ben-Dov, P. Briata, R. Gherzi, T. Naveh-Many, The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. FASEB J. 22(10), 3458\u20133468 (2008). https:\/\/doi.org\/10.1096\/fj.08-107250","journal-title":"FASEB J."},{"issue":"1","key":"4092_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"M.C. Hu, K. Shiizaki, M. Kuro-o, O.W. Moe, Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev. Physiol. 75(1), 503\u2013533 (2013). https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183727","journal-title":"Annu Rev. Physiol."},{"issue":"9","key":"4092_CR49","doi-asserted-by":"publisher","first-page":"e1603259","DOI":"10.1126\/sciadv.1603259","volume":"3","author":"M Eren","year":"2017","unstructured":"M. Eren, A.T. Place, P.M. Thomas, P. Flevaris, T. Miyata, D.E. Vaughan, PAI-1 is a critical regulator of FGF23 homeostasis. Sci. Adv. 3(9), e1603259 (2017). https:\/\/doi.org\/10.1126\/sciadv.1603259","journal-title":"Sci. Adv."},{"issue":"15","key":"4092_CR50","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1073\/pnas.1402218111","volume":"111","author":"VS Tagliabracci","year":"2014","unstructured":"V.S. Tagliabracci, J.L. Engel, S.E. Wiley et al. Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc. Natl Acad. Sci. USA 111(15), 5520\u20135525 (2014). https:\/\/doi.org\/10.1073\/pnas.1402218111","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"5","key":"4092_CR51","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"S. Liu, W. Tang, J. Zhou et al. Fibroblast growth factor 23 Is a counter-regulatory phosphaturic hormone for vitamin D. J. Am. Soc. Nephrol. 17(5), 1305\u20131315 (2006). https:\/\/doi.org\/10.1681\/ASN.2005111185","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"4092_CR52","doi-asserted-by":"publisher","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","volume":"299","author":"V Lavi-Moshayoff","year":"2010","unstructured":"V. Lavi-Moshayoff, G. Wasserman, T. Meir, J. Silver, T. Naveh-Many, PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am. J. Physiol. Ren. Physiol. 299(4), F882\u2013F889 (2010). https:\/\/doi.org\/10.1152\/ajprenal.00360.2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"11","key":"4092_CR53","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1210\/en.2009-0472","volume":"150","author":"R Samadfam","year":"2009","unstructured":"R. Samadfam, C. Richard, L. Nguyen-Yamamoto, I. Bolivar, D. Goltzman, Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150(11), 4835\u20134845 (2009). https:\/\/doi.org\/10.1210\/en.2009-0472","journal-title":"Endocrinology"},{"issue":"1","key":"4092_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.surg.2015.06.057","volume":"159","author":"IL Nilsson","year":"2016","unstructured":"I.L. Nilsson, S. Norenstedt, F. Granath, J. Zedenius, Y. Pernow, T.E. Larsson, FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomy. Surgery 159(1), 211\u2013217 (2016). https:\/\/doi.org\/10.1016\/j.surg.2015.06.057","journal-title":"Surgery"},{"issue":"1","key":"4092_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-11-0523","volume":"166","author":"JE Witteveen","year":"2012","unstructured":"J.E. Witteveen, A.H. van Lierop, S.E. Papapoulos, N.A.T. Hamdy, Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism? Eur. J. Endocrinol. 166(1), 55\u201360 (2012). https:\/\/doi.org\/10.1530\/EJE-11-0523","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4092_CR56","doi-asserted-by":"publisher","first-page":"e210430","DOI":"10.1530\/EC-21-0430","volume":"11","author":"M Fo\u0159tov\u00e1","year":"2022","unstructured":"M. Fo\u0159tov\u00e1, L. Hanouskov\u00e1, M. Valkus, J. \u010cepov\u00e1, R. Pr\u016f\u0161a, K. Kota\u0161ka, Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism. Endocr. Connect 11(1), e210430 (2022). https:\/\/doi.org\/10.1530\/EC-21-0430","journal-title":"Endocr. Connect"},{"issue":"2","key":"4092_CR57","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S2213-8587(19)30426-7","volume":"8","author":"P Florenzano","year":"2020","unstructured":"P. Florenzano, C. Cipriani, K.L. Roszko et al. Approach to patients with hypophosphataemia. Lancet Diab. Endocrinol. 8(2), 163\u2013174 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(19)30426-7","journal-title":"Lancet Diab. Endocrinol."},{"issue":"1","key":"4092_CR58","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00223-020-00665-8","volume":"108","author":"J Bacchetta","year":"2021","unstructured":"J. Bacchetta, J. Bernardor, C. Garnier, C. Naud, B. Ranchin, Hyperphosphatemia and chronic kidney disease: a major daily concern both in adults and in children. Calcif. Tissue Int 108(1), 116\u2013127 (2021). https:\/\/doi.org\/10.1007\/s00223-020-00665-8","journal-title":"Calcif. Tissue Int"},{"issue":"10","key":"4092_CR59","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJM198503073121003","volume":"312","author":"M Tieder","year":"1985","unstructured":"M. Tieder, D. Modai, R. Samuel et al. Hereditary hypophosphatemic rickets with hypercalciuria. N. Engl. J. Med 312(10), 611\u2013617 (1985). https:\/\/doi.org\/10.1056\/NEJM198503073121003","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"4092_CR60","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/8756-3282(86)90355-8","volume":"7","author":"M Tieder","year":"1986","unstructured":"M. Tieder, D. Modal, U. Shaked et al. Idiopathic hypercalciuria (I.H.) and hereditary hypophosphatemia rickets (H.H.R.H.)\u2014Two phenotypical expressions of a common genetic defect. Bone 7(5), 414\u2013415 (1986). https:\/\/doi.org\/10.1016\/8756-3282(86)90355-8","journal-title":"Bone"},{"issue":"2","key":"4092_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000187029","volume":"62","author":"M Tieder","year":"1992","unstructured":"M. Tieder, R. Arie, I. Bab, J. Maor, U.A. Liberman, A new kindred with hereditary hypophosphatemic rickets with hypercalciuria: implications for correct diagnosis and treatment. Nephron 62(2), 176\u2013181 (1992). https:\/\/doi.org\/10.1159\/000187029","journal-title":"Nephron"},{"issue":"2","key":"4092_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1086\/499409","volume":"78","author":"C Bergwitz","year":"2006","unstructured":"C. Bergwitz, N.M. Roslin, M. Tieder et al. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am. J. Hum. Genet. 78(2), 179\u2013192 (2006). https:\/\/doi.org\/10.1086\/499409","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"4092_CR63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.V123507","volume":"12","author":"AO Jones","year":"2001","unstructured":"A.O. Jones, J. Tzenova, D. Frappier et al. Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na\/Pi cotransporter NPT2 gene. J. Am. Soc. Nephrol. 12(3), 507\u2013514 (2001). https:\/\/doi.org\/10.1681\/ASN.V123507","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"4092_CR64","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000045964","volume":"88","author":"I Sermet-Gaudelus","year":"2001","unstructured":"I. Sermet-Gaudelus, M. Garab\u00e9dian, M. Dechaux, G. Lenoir, J. Rey, M. Tieder, Hereditary hypophosphatemic rickets with hypercalciuria: report of a new kindred. Nephron 88(1), 83\u201386 (2001). https:\/\/doi.org\/10.1159\/000045964","journal-title":"Nephron"},{"issue":"12","key":"4092_CR65","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1056\/NEJMoa0905647","volume":"362","author":"D Magen","year":"2010","unstructured":"D. Magen, L. Berger, M.J. Coady et al. A loss-of-function mutation in napi-iia and renal fanconi\u2019s syndrome. N. Engl. J. Med. 362(12), 1102\u20131109 (2010). https:\/\/doi.org\/10.1056\/NEJMoa0905647","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"4092_CR66","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1056\/NEJMoa020028","volume":"347","author":"D Pri\u00e9","year":"2002","unstructured":"D. Pri\u00e9, V. Huart, N. Bakouh et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the Type 2a sodium\u2013phosphate cotransporter. N. Engl. J. Med. 347(13), 983\u2013991 (2002). https:\/\/doi.org\/10.1056\/NEJMoa020028","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"4092_CR67","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/jbmr.4630","volume":"37","author":"J St\u00fcrznickel","year":"2020","unstructured":"J. St\u00fcrznickel, F. Heider, A. Delsmann et al. Clinical spectrum of hereditary hypophosphatemic rickets with hypercalciuria (HHRH). J. Bone Miner. Res. 37(8), 1580\u20131591 (2020). https:\/\/doi.org\/10.1002\/jbmr.4630","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"4092_CR68","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357(3), 266\u2013281 (2007). https:\/\/doi.org\/10.1056\/NEJMra070553","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"4092_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11914-015-0259-y","volume":"13","author":"BK Goldsweig","year":"2015","unstructured":"B.K. Goldsweig, T.O. Carpenter, Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis. Curr. Osteoporos. Rep. 13(2), 88\u201397 (2015). https:\/\/doi.org\/10.1007\/s11914-015-0259-y","journal-title":"Curr. Osteoporos. Rep."},{"issue":"11","key":"4092_CR70","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1681\/ASN.2009050559","volume":"20","author":"Y Sabbagh","year":"2009","unstructured":"Y. Sabbagh, S.P. O\u2019Brien, W. Song et al. Intestinal Npt2b plays a major role in phosphate absorption and homeostasis. J. Am. Soc. Nephrol. 20(11), 2348\u20132358 (2009). https:\/\/doi.org\/10.1681\/ASN.2009050559","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"4092_CR71","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"F Francis","year":"1995","unstructured":"F. Francis, S. Hennig, B. Korn et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X\u2013linked hypophosphatemic rickets. Nat. Genet 11(2), 130\u2013136 (1995). https:\/\/doi.org\/10.1038\/ng1095-130","journal-title":"Nat. Genet"},{"issue":"5","key":"4092_CR72","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/metabo12050401","volume":"12","author":"MG Vervloet","year":"2022","unstructured":"M.G. Vervloet, Shedding light on the complex regulation of FGF23. Metabolites 12(5), 401 (2022). https:\/\/doi.org\/10.3390\/metabo12050401","journal-title":"Metabolites"},{"key":"4092_CR73","doi-asserted-by":"publisher","unstructured":"Rickets. Nat Rev Dis Primers. 3(1):17102 (2017) https:\/\/doi.org\/10.1038\/nrdp.2017.102","DOI":"10.1038\/nrdp.2017.102"},{"issue":"3","key":"4092_CR74","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"KE White","year":"2000","unstructured":"K.E. White, W.E. Evans, J.L.H. O\u2019Riordan et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet 26(3), 345\u2013348 (2000). https:\/\/doi.org\/10.1038\/81664","journal-title":"Nat. Genet"},{"issue":"11","key":"4092_CR75","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"B. Lorenz-Depiereux, M. Bastepe, A. Benet-Pag\u00e8s et al. DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat. Genet 38(11), 1248\u20131250 (2006). https:\/\/doi.org\/10.1038\/ng1868","journal-title":"Nat. Genet"},{"issue":"11","key":"4092_CR76","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Y. Yamazaki, R. Okazaki, M. Shibata et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J. Clin. Endocrinol. Metab. 87(11), 4957\u20134960 (2002). https:\/\/doi.org\/10.1210\/jc.2002-021105","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4092_CR77","doi-asserted-by":"publisher","unstructured":"Fishman G., Miller-Hansen D., Jacobsen C., Singhal Virender K., Alon U. Hearing impairment in familial X-linked hypophosphatemic rickets. Eur. J. Pediatr. (2004). https:\/\/doi.org\/10.1007\/s00431-004-1504-z","DOI":"10.1007\/s00431-004-1504-z"},{"issue":"2","key":"4092_CR78","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00860736","volume":"9","author":"A Taylor","year":"1995","unstructured":"A. Taylor, N.H. Sherman, M.E. Norman, Nephrocalcinosis in X-linked hypophosphatemia: effect of treatment versus disease. Pediatr. Nephrol. 9(2), 173\u2013175 (1995). https:\/\/doi.org\/10.1007\/BF00860736","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"4092_CR79","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00467-002-1044-6","volume":"18","author":"US Alon","year":"2003","unstructured":"U.S. Alon, R. Monzavi, M. Lilien, M. Rasoulpour, M.E. Geffner, O. Yadin, Hypertension in hypophosphatemic rickets\u2014role of secondary hyperparathyroidism. Pediatr. Nephrol. 18(2), 155\u2013158 (2003). https:\/\/doi.org\/10.1007\/s00467-002-1044-6","journal-title":"Pediatr. Nephrol."},{"issue":"8","key":"4092_CR80","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","volume":"82","author":"R Nehgme","year":"1997","unstructured":"R. Nehgme, J.T. Fahey, C. Smith, T.O. Carpenter, Cardiovascular Abnormalities in Patients with X-Linked Hypophosphatemia. J. Clin. Endocrinol. Metab. 82(8), 2450\u20132454 (1997). https:\/\/doi.org\/10.1210\/jcem.82.8.4181","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4092_CR81","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0661","volume":"174","author":"H Che","year":"2016","unstructured":"H. Che, C. Roux, A. Etcheto et al. Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur. J. Endocrinol. 174(3), 325\u2013333 (2016). https:\/\/doi.org\/10.1530\/EJE-15-0661","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"4092_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"S.S. Beck-Nielsen, Z. Mughal, D. Haffner et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J. Rare Dis. 14(1), 58 (2019). https:\/\/doi.org\/10.1186\/s13023-019-1014-8","journal-title":"Orphanet J. Rare Dis."},{"key":"4092_CR83","doi-asserted-by":"publisher","first-page":"e12295","DOI":"10.7717\/peerj.12295","volume":"9","author":"J Nie","year":"2021","unstructured":"J. Nie, Q. Li, M. Guo et al. The correlation between fibroblast growth factor-23 and ESRD patients with hearing impairment. PeerJ 9, e12295 (2021). https:\/\/doi.org\/10.7717\/peerj.12295","journal-title":"PeerJ"},{"issue":"7","key":"4092_CR84","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s004670050669","volume":"13","author":"TD Blydt-Hansen","year":"1999","unstructured":"T.D. Blydt-Hansen, H.S. Tenenhouse, P. Goodyer, PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia. Pediatr. Nephrol. 13(7), 607\u2013611 (1999). https:\/\/doi.org\/10.1007\/s004670050669","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"4092_CR85","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2265.1995.tb01863.x","volume":"42","author":"J Knudtzon","year":"1995","unstructured":"J. Knudtzon, J. Halse, E. Monn et al. Autonomous hyperparathyroidism in X\u2010linked hypophosphataemia. Clin. Endocrinol. 42(2), 199\u2013203 (1995). https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb01863.x","journal-title":"Clin. Endocrinol."},{"issue":"26","key":"4092_CR86","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","volume":"325","author":"CF Verge","year":"1991","unstructured":"C.F. Verge, A. Lam, J.M. Simpson, C.T. Cowell, N.J. Howard, M. Silink, Effects of therapy in X-linked hypophosphatemic rickets. N. Engl. J. Med 325(26), 1843\u20131848 (1991). https:\/\/doi.org\/10.1056\/NEJM199112263252604","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"4092_CR87","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00008480-200108000-00015","volume":"13","author":"KC Moltz","year":"2001","unstructured":"K.C. Moltz, A.H. Friedman, R.A. Nehgme, C.S. Kleinman, T.O. Carpenter, Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. Curr. Opin. Pediatrics 13(4), 373\u2013375 (2001). https:\/\/doi.org\/10.1097\/00008480-200108000-00015","journal-title":"Curr. Opin. Pediatrics"},{"issue":"3","key":"4092_CR88","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1210\/jcem.75.3.1517380","volume":"75","author":"W Sullivan","year":"1992","unstructured":"W. Sullivan, T. Carpenter, F. Glorieux, R. Travers, K. Insogna, A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 75(3), 879\u2013885 (1992). https:\/\/doi.org\/10.1210\/jcem.75.3.1517380","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4092_CR89","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13052-019-0654-6","volume":"45","author":"F Emma","year":"2019","unstructured":"F. Emma, M. Cappa, F. Antoniazzi et al. X-linked hypophosphatemic rickets: an Italian experts\u2019 opinion survey. Ital. J. Pediatr. 45(1), 67 (2019). https:\/\/doi.org\/10.1186\/s13052-019-0654-6","journal-title":"Ital. J. Pediatr."},{"key":"4092_CR90","doi-asserted-by":"publisher","unstructured":"Krohn P.H., Offermann G., Brandis M., Brodehl J., Hanke K., Offner G. Occurrence of Hyperparathyroidism in Children with X-Linked Hypophosphatemia under Treatment with Vitamin D and Phosphate. In: Massry SG, Ritz E, eds. Phosphate Metabolism. Vol 81. Advances in Experimental Medicine and Biology. Springer US; 1977:345-351. https:\/\/doi.org\/10.1007\/978-1-4613-4217-5_34","DOI":"10.1007\/978-1-4613-4217-5_34"},{"key":"4092_CR91","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","volume":"56","author":"E Slatopolsky","year":"1999","unstructured":"E. Slatopolsky, A. Brown, A. Dusso, Pathogenesis of secondary hyperparathyroidism. Kidney Int. 56, S14\u2013S19 (1999). https:\/\/doi.org\/10.1046\/j.1523-1755.1999.07304.x","journal-title":"Kidney Int."},{"key":"4092_CR92","unstructured":"Brown E.M. Calcium receptor and regulation of parathyroid hormone secretion."},{"issue":"6","key":"4092_CR93","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1210\/endo-104-6-1778","volume":"104","author":"GP Maye","year":"1979","unstructured":"G.P. Maye, J.A. Keaton, J.G. Hurst, J.F. Habener, Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood. Endocrinology 104(6), 1778\u20131784 (1979). https:\/\/doi.org\/10.1210\/endo-104-6-1778","journal-title":"Endocrinology"},{"issue":"5","key":"4092_CR94","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00467-004-1443-y","volume":"19","author":"CP Schmitt","year":"2004","unstructured":"C.P. Schmitt, O. Mehls, The enigma of hyperparathyroidism in hypophosphatemic rickets. Pediatr. Nephrol. 19(5), 473\u2013477 (2004). https:\/\/doi.org\/10.1007\/s00467-004-1443-y","journal-title":"Pediatr. Nephrol."},{"issue":"9","key":"4092_CR95","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","volume":"11","author":"PK Nielsen","year":"1996","unstructured":"P.K. Nielsen, U. Feldt-Rasmussen, K. Olgaard, A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol. Dialysis Transplant. 11(9), 1762\u20131768 (1996). https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a027665","journal-title":"Nephrol. Dialysis Transplant."},{"issue":"3","key":"4092_CR96","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","volume":"283","author":"J Silver","year":"2002","unstructured":"J. Silver, R. Kilav, T. Naveh-Many, Mechanisms of secondary hyperparathyroidism. Am. J. Physiol.-Ren. Physiol. 283(3), F367\u2013F376 (2002). https:\/\/doi.org\/10.1152\/ajprenal.00061.2002","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"issue":"3","key":"4092_CR97","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1681\/ASN.V133693","volume":"13","author":"Y Almad\u00e9n","year":"2002","unstructured":"Y. Almad\u00e9n, A. Canalejo, E. Ballesteros, G. A\u00f1\u00f3n, S. Ca\u00f1adillas, M. Rodr\u00edguez, Regulation of arachidonic acid production by intracellular calcium in parathyroid cells: effect of extracellular phosphate. J. Am. Soc. Nephrol. 13(3), 693\u2013698 (2002). https:\/\/doi.org\/10.1681\/ASN.V133693","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"4092_CR98","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2215\/CJN.04981107","volume":"3","author":"US Alon","year":"2008","unstructured":"U.S. Alon, R. Levy-Olomucki, W.V. Moore, J. Stubbs, S. Liu, L.D. Quarles, Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin. J. Am. Soc. Nephrol. 3(3), 658\u2013664 (2008). https:\/\/doi.org\/10.2215\/CJN.04981107","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"4092_CR99","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1210\/jcem.78.6.8200940","volume":"78","author":"TO Carpenter","year":"1994","unstructured":"T.O. Carpenter, M.A. Mitnick, A. Ellison, C. Smith, K.L. Insogna, Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia. J. Clin. Endocrinol. Metab. 78(6), 1378\u20131383 (1994). https:\/\/doi.org\/10.1210\/jcem.78.6.8200940","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4092_CR100","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ki.1985.220","volume":"28","author":"AJ Adler","year":"1985","unstructured":"A.J. Adler, N. Ferran, G.M. Berlyne, Effect of inorganic phosphate on serum ionized calcium concentration in vitro: a reassessment of the \u201ctrade-off hypothesis. Kidney Int. 28(6), 932\u2013935 (1985). https:\/\/doi.org\/10.1038\/ki.1985.220","journal-title":"Kidney Int."},{"key":"4092_CR101","doi-asserted-by":"publisher","unstructured":"Ritz E., Malluche H.H., Krempien B., Tschope W., Massry S.G. Pathogenesis of Renal Osteodystrophy: Roles of Phosphate and Skeletal Resistance to PTH. In: Massry SG, Ritz E, Rapado A, eds. Homeostasis of Phosphate and Other Minerals. Vol 103. Advances in Experimental Medicine and Biology. Springer US; 1978:423\u2013436. https:\/\/doi.org\/10.1007\/978-1-4684-7758-0_44","DOI":"10.1007\/978-1-4684-7758-0_44"},{"issue":"5","key":"4092_CR102","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1172\/JCI112714","volume":"78","author":"J Silver","year":"1986","unstructured":"J. Silver, T. Naveh-Many, H. Mayer, H.J. Schmelzer, M.M. Popovtzer, Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J. Clin. Invest 78(5), 1296\u20131301 (1986). https:\/\/doi.org\/10.1172\/JCI112714","journal-title":"J. Clin. Invest"},{"issue":"3","key":"4092_CR103","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00223-011-9505-1","volume":"89","author":"FJA De Paula","year":"2011","unstructured":"F.J.A. De Paula, I. Dick-de-Paula, S. Bornstein et al. VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender-specific manner. Calcif. Tissue Int. 89(3), 179\u2013191 (2011). https:\/\/doi.org\/10.1007\/s00223-011-9505-1","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"4092_CR104","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00016.2003","volume":"285","author":"LD Quarles","year":"2003","unstructured":"L.D. Quarles, FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am. J. Physiol.-Endocrinol. Metab. 285(1), E1\u2013E9 (2003). https:\/\/doi.org\/10.1152\/ajpendo.00016.2003","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"9","key":"4092_CR105","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.273.9.5253","volume":"273","author":"E Moallem","year":"1998","unstructured":"E. Moallem, R. Kilav, J. Silver, T. Naveh-Many, RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J. Biol. Chem. 273(9), 5253\u20135259 (1998). https:\/\/doi.org\/10.1074\/jbc.273.9.5253","journal-title":"J. Biol. Chem."},{"issue":"12","key":"4092_CR106","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1210\/en.2005-0777","volume":"146","author":"F Perwad","year":"2005","unstructured":"F. Perwad, N. Azam, M.Y.H. Zhang, T. Yamashita, H.S. Tenenhouse, A.A. Portale, Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146(12), 5358\u20135364 (2005). https:\/\/doi.org\/10.1210\/en.2005-0777","journal-title":"Endocrinology"},{"issue":"8","key":"4092_CR107","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SAM Burnett","year":"2006","unstructured":"S.A.M. Burnett, S.C. Gunawardene, F.R. Bringhurst, H. J\u00fcppner, H. Lee, J.S. Finkelstein, Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J. Bone Miner. Res. 21(8), 1187\u20131196 (2006). https:\/\/doi.org\/10.1359\/jbmr.060507","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"4092_CR108","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1359\/JBMR.050718","volume":"20","author":"MT Collins","year":"2005","unstructured":"M.T. Collins, J.R. Lindsay, A. Jain et al. Fibroblast growth factor-23 Is regulated by 1\u03b1,25-dihydroxyvitamin D. J. Bone Miner. Res. 20(11), 1944\u20131950 (2005). https:\/\/doi.org\/10.1359\/JBMR.050718","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"4092_CR109","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"E.A. Imel, L.A. DiMeglio, S.L. Hui, T.O. Carpenter, M.J. Econs, Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J. Clin. Endocrinol. Metab. 95(4), 1846\u20131850 (2010). https:\/\/doi.org\/10.1210\/jc.2009-1671","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"4092_CR110","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1210\/jc.2010-0589","volume":"95","author":"TO Carpenter","year":"2010","unstructured":"T.O. Carpenter, K.L. Insogna, J.H. Zhang et al. Circulating levels of soluble klotho and FGF23 in X-Linked Hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J. Clin. Endocrinol. Metab. 95(11), E352\u2013E357 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0589","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4092_CR111","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1210\/jc.75.6.1514","volume":"75","author":"SA Rivkees","year":"1992","unstructured":"S.A. Rivkees, Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 75(6), 1514\u20131518 (1992). https:\/\/doi.org\/10.1210\/jc.75.6.1514","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"4092_CR112","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"K.L. Insogna, K. Briot, E.A. Imel et al. A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with x-linked hypophosphatemia: week 24 primary analysis. J. Bone Miner. Res. 33(8), 1383\u20131393 (2018). https:\/\/doi.org\/10.1002\/jbmr.3475","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"4092_CR113","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jbmr.3843","volume":"34","author":"KL Insogna","year":"2019","unstructured":"K.L. Insogna, F. Rauch, P. Kamenick\u00fd et al. Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial. J. Bone Miner. Res. 34(12), 2183\u20132191 (2019). https:\/\/doi.org\/10.1002\/jbmr.3843","journal-title":"J. Bone Miner. Res."},{"key":"4092_CR114","doi-asserted-by":"publisher","first-page":"1004624","DOI":"10.3389\/fendo.2022.1004624","volume":"13","author":"Y Takashi","year":"2022","unstructured":"Y. Takashi, K. Toyokawa, N. Oda et al. Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report. Front Endocrinol. 13, 1004624 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.1004624","journal-title":"Front Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04092-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T07:33:49Z","timestamp":1742801629000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04092-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["4092"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04092-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"29 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}